SCHEMBL19659252

SCHEMBL19659252

NC(=O)c1nc2cccc(-c3cc(F)ccc3F)n2n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ FYN P06241 1/20 0.36
▸ NUDT1 P36639 2/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ CDC7 O00311 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ DBF4 Q9UBU7 1/20 0.35
▸ JAK2 O60674 2/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ EGLN2 Q96KS0 2/20 0.35
▸ KIF11 P52732 4/20 0.35
▸ SLC9A1 P19634 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19659253 0.85 EGLN2 (0.50) NUDT1GRM2PARP1JAK2JAK1
SCHEMBL19658700 0.80 NUDT1 (0.38) NUDT1PARP1JAK2JAK1TYK2
SCHEMBL2730240 0.74 NUDT1 (0.62) KDM4EALDH1A1FYNNUDT1PARP1
SCHEMBL22439076 0.73 KDM4E (0.43) KDM4EALDH1A1HPGDNUDT1PARP1
SCHEMBL23754207 0.71 JAK1 (0.51) KDM4EALDH1A1HPGDJAK2JAK1
SCHEMBL28485655 0.70 AHR (0.47) KDM4EALDH1A1NUDT1PARP1
SCHEMBL19659614 0.70 KDM4E (0.43) KDM4EALDH1A1HPGDPARP1
SCHEMBL19658956 0.67 PARP1 (0.39) KDM4EALDH1A1NUDT1PARP1JAK2
SCHEMBL19658973 0.67 L3MBTL1 (0.36) KDM4EALDH1A1NUDT1PARP1JAK2
SCHEMBL23754392 0.66 JAK2 (0.51) KDM4EALDH1A1HPGDJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 — — EP disclosed
WO-2017004500-A9 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
Send feedback